U.S. Markets open in 1 hr 10 mins
  • S&P Futures

    +58.75 (+1.47%)
  • Dow Futures

    +361.00 (+1.12%)
  • Nasdaq Futures

    +228.75 (+1.87%)
  • Russell 2000 Futures

    +30.70 (+1.72%)
  • Crude Oil

    +0.76 (+0.67%)
  • Gold

    +18.90 (+1.04%)
  • Silver

    +0.20 (+0.95%)

    +0.0101 (+0.9696%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    -2.28 (-7.90%)

    +0.0156 (+1.2629%)

    +0.3320 (+0.2573%)

    +685.93 (+2.31%)
  • CMC Crypto 200

    +441.05 (+181.74%)
  • FTSE 100

    +58.83 (+0.79%)
  • Nikkei 225

    +112.70 (+0.42%)

Diversified Healthcare Trust (NASDAQ:DHC) Share Prices Have Dropped 73% In The Last Three Years

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

It is a pleasure to report that the Diversified Healthcare Trust (NASDAQ:DHC) is up 46% in the last quarter. But that is small recompense for the exasperating returns over three years. Tragically, the share price declined 73% in that time. So it is really good to see an improvement. While many would remain nervous, there could be further gains if the business can put its best foot forward.

View our latest analysis for Diversified Healthcare Trust

Diversified Healthcare Trust isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

In the last three years, Diversified Healthcare Trust saw its revenue grow by 8.2% per year, compound. That's a fairly respectable growth rate. So it seems unlikely the 20% share price drop (each year) is entirely about the revenue. More likely, the market was spooked by the cost of that revenue. This is exactly why investors need to diversify - even when a loss making company grows revenue, it can fail to deliver for shareholders.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).


If you are thinking of buying or selling Diversified Healthcare Trust stock, you should check out this FREE detailed report on its balance sheet.

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. As it happens, Diversified Healthcare Trust's TSR for the last 3 years was -67%, which exceeds the share price return mentioned earlier. The dividends paid by the company have thusly boosted the total shareholder return.

A Different Perspective

Diversified Healthcare Trust shareholders are down 43% for the year (even including dividends), but the market itself is up 26%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 9% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 2 warning signs we've spotted with Diversified Healthcare Trust (including 1 which makes us a bit uncomfortable) .

We will like Diversified Healthcare Trust better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.